Literature DB >> 20087665

High risk for neoplastic transformation of endometriosis in a carrier of Lynch syndrome.

Christine Nyiraneza1, Etienne Marbaix, Mireille Smets, Christine Galant, Christine Sempoux, Karin Dahan.   

Abstract

Lynch syndrome is an autosomal dominant cancer-susceptibility disorder caused by mutations in DNA mismatch repair genes. Women with Lynch syndrome have an increased lifetime risk for endometrial and ovarian cancers. While there is evidence of efficacy for prophylactic surgery, no standard recommendations have been developed to support screening for premalignant endometrial and ovarian epithelial lesions in high-risk women. Here, we report a case of a healthy woman carrying a germline mutation in MLH1 gene with endometrial intra-epithelial neoplasia and ovarian endometriotic lesions exhibiting a loss of MLH1 protein expression. This case report illustrates the malignant potential of endometriosis, and highlights the need for a meticulous management of gynecologic premalignant precursor lesions in reducing cancer risk among related Lynch syndrome women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20087665     DOI: 10.1007/s10689-010-9321-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  24 in total

1.  Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome.

Authors:  N Rahner; N Friedrichs; V Steinke; S Aretz; W Friedl; R Buettner; E Mangold; P Propping; C Walldorf
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

2.  Molecular genetic evidence that endometriosis is a precursor of ovarian cancer.

Authors:  Amanda H Prowse; Sanjiv Manek; Rajesh Varma; Jinsong Liu; Andrew K Godwin; Eamonn R Maher; Ian P M Tomlinson; Stephen H Kennedy
Journal:  Int J Cancer       Date:  2006-08-01       Impact factor: 7.396

3.  hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis.

Authors:  M Esteller; L Catasus; X Matias-Guiu; G L Mutter; J Prat; S B Baylin; J G Herman
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.

Authors:  Kathleen M Schmeler; Henry T Lynch; Lee-may Chen; Mark F Munsell; Pamela T Soliman; Mary Beth Clark; Molly S Daniels; Kristin G White; Stephanie G Boyd-Rogers; Peggy G Conrad; Kathleen Y Yang; Mary M Rubin; Charlotte C Sun; Brian M Slomovitz; David M Gershenson; Karen H Lu
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

5.  Mechanisms of inactivation of MLH1 in hereditary nonpolyposis colorectal carcinoma: a novel approach.

Authors:  M Ollikainen; U Hannelius; C M Lindgren; W M Abdel-Rahman; J Kere; P Peltomäki
Journal:  Oncogene       Date:  2007-01-29       Impact factor: 9.867

6.  MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers.

Authors:  S B Simpkins; T Bocker; E M Swisher; D G Mutch; D J Gersell; A J Kovatich; J P Palazzo; R Fishel; P J Goodfellow
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

7.  Germline hMSH2 and hMLH1 gene mutations in incomplete HNPCC families.

Authors:  Q Wang; F Desseigne; C Lasset; J C Saurin; C Navarro; T Yagci; I Keser; H Bagci; G Luleci; T Gelen; J A Chayvialle; A Puisieux; M Ozturk
Journal:  Int J Cancer       Date:  1997-12-10       Impact factor: 7.396

8.  Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma.

Authors:  Kari Hemminki; Lauri Aaltonen; Xinjun Li
Journal:  Cancer       Date:  2003-05-15       Impact factor: 6.860

Review 9.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

10.  Primary peritoneal clear cell adenocarcinoma arising in previous abdominal scar for endometriosis surgery.

Authors:  Koji Matsuo; Edgar L C Alonsozana; Michele L Eno; Neil B Rosenshein; Dwight D Im
Journal:  Arch Gynecol Obstet       Date:  2009-02-15       Impact factor: 2.344

View more
  4 in total

1.  Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.

Authors:  Murray Joseph Casey; Chhanda Bewtra; Henry T Lynch; Carrie Snyder; Mark Stacy; Patrice Watson
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

2.  Genetic burden associated with varying degrees of disease severity in endometriosis.

Authors:  Yadav Sapkota; John Attia; Scott D Gordon; Anjali K Henders; Elizabeth G Holliday; Nilufer Rahmioglu; Stuart MacGregor; Nicholas G Martin; Mark McEvoy; Andrew P Morris; Rodney J Scott; Krina T Zondervan; Grant W Montgomery; Dale R Nyholt
Journal:  Mol Hum Reprod       Date:  2015-04-16       Impact factor: 4.025

Review 3.  Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy.

Authors:  Yoriko Yamashita
Journal:  Jpn J Clin Oncol       Date:  2015-01-12       Impact factor: 3.019

4.  AT-rich interactive domain1A determines sensitivity to oxaliplatin in gastric cancer cells.

Authors:  Qing Liu; Qing-Qing Weng; Song-Fei Shen; Tao Jiang; Zhang-Chi Pan; Meng-Xin Lin; Yan-Qin Lan; Yao Wang; Qiang Chen; Chun-Mei Shi
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.